DAYANA PAUL-DUROCHER: Open Payments
NPI 1386005619 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 21 payments from 4 companies in 2025. Trend: 2023 $154 · 2024 $346 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $253 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Amphastar Pharmaceuticals, Inc. | 1 | $20 |
Products named: RINVOQ, LINZESS, SKYRIZI, XIFAXAN, IQIRVO, CREON.
Industry payments across PA — which companies pay providers there.
